Autonomic effects and ablation success after pulsed field and cryoballoon ablation – A SINGLE SHOT CHAMPION substudy
BACKGROUND: Pulmonary vein isolation (PVI) using radiofrequency and cryoballoon ablation (CBA) modulates the cardiac autonomic nervous system (ANS) by affecting epicardial ganglionated plexi. In contrast, pulsed field ablation (PFA) appears to exert minimal autonomic effects. The impact of cardiac ANS modulation on arrhythmia recurrence remains incompletely understood. METHODS: In this multicenter trial substudy, 210 patients with symptomatic paroxysmal atrial fibrillation (AF) were randomized 1:1 to PVI using PFA or CBA. All patients received an implantable cardiac monitor at the time of ablation. Daytime heart rate (DHR), nighttime heart rate (NHR), and heart rate variability (HRV) were continuously recorded over 12 months and analyzed at day 1-2, month 3, 6, 9, and 12 post-ablation, and related to arrhythmia-free outcome. RESULTS: PFA (n = 105) was associated with higher HRV at day 1-2 compared to CBA (n = 105; 100 [79-122] ms vs. 73 [59-93] ms, p < 0.001). This trend persisted throughout follow-up. DHR and NHR were also consistently lower in the PFA group. Freedom from arrhythmia recurrence at 12 months was higher with PFA than CBA (63% vs. 49%, p = 0.046). HRV did not differ between PFA patients with and without recurrence. A stronger initial HRV suppression predicted favorable outcomes in CBA patients (67 ms vs. 84 ms in patients without vs. with arrhythmia recurrence, p = 0.002). CONCLUSIONS: Despite reduced cardiac ANS modulation, PFA was associated with a superior arrhythmia-free outcome compared to CBA. These findings suggest that cardiac ANS modulation may not be critical for the successful ablation of paroxysmal AF.
Authors
- Philipp Krisai (ORCID: https://orcid.org/0000-0002-4367-2363)
- Laurent Roten (ORCID: https://orcid.org/0000-0002-0827-1329)
- Thomas Kueffer (ORCID: https://orcid.org/0000-0003-3553-4945)
- Helge Servatius (ORCID: https://orcid.org/0000-0003-2887-8707)
- Felix Mahfoud (ORCID: https://orcid.org/0000-0002-4425-549X)
- Nikola Kozhuharov (ORCID: https://orcid.org/0000-0003-2086-3690)
- Peter Jüni (ORCID: https://orcid.org/0000-0002-5985-0670)
- Salik ur Rehman Iqbal (ORCID: https://orcid.org/0000-0001-6361-1130)
- Dik Heg (ORCID: https://orcid.org/0000-0002-8766-7945)
- Gregor Thalmann (ORCID: https://orcid.org/0000-0002-2050-6311)
- Michael Kühne (ORCID: https://orcid.org/0000-0002-2937-3711)
- Patrick Badertscher (ORCID: https://orcid.org/0000-0001-9751-0557)
- Jens Maurhofer (ORCID: https://orcid.org/0000-0003-4442-8941)
- Sven Knecht (ORCID: https://orcid.org/0000-0001-7122-021X)
- Hildegard Tanner (ORCID: https://orcid.org/0000-0001-9722-5617)
- Christian Sticherling (ORCID: https://orcid.org/0000-0001-8428-7050)
- Tobias Reichlin (ORCID: https://orcid.org/0000-0002-7197-8415)
- Corinne Jufer
- Tiago Veiga Pereira
Institutions
- University of Bern (CH)
- Bern University of Applied Sciences (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- University of Oxford (GB)
Publication Details
- Journal
- EP Europace
- Published
- 2026-06-16
- DOI
- https://doi.org/10.1093/europace/euag152
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00